Liver non-contrast perfusion in diffuse liver diseases diagnostic algorithm: the new diagnostic criteria
https://doi.org/10.24835/1607-0763-1419
Abstract
Purpose: to define the new criteria for contrast-free ASL perfusion using for the management of diffuse liver diseases (DLD).
Material and methods. Clinical and laboratory data, results of MRI with non-contrast MR perfusion (ASL-perfusion) of the liver were estimated in a group of patients with DLD (three-year research).
Results. Potentials of assessment of liver ASL perfusion for patients with DLD (including complicated cases) are described in the article. It was established that ASL liver perfusion is useful for DLD clinical forms differential diagnosis, predicting the risk of liver cirrhosis, as well as complications (hepatic encephalopathy, sialoadenitis) and DLD exacerbation. The strategy of contrast-free MR perfusion using in patients with DLD management algorithm was developed.
Conclusion. Liver ASL perfusion is a promising for the study and application method for the management of DLD.
About the Authors
A. A. Telesh
Smolensk State Medical University;
Main Military Clinical Hospital named after academician N.N. Burdenko Russian Defense Ministry
Russian Federation
Russian Federation
Arina A. Telesh – Postgraduate student of Smolensk State Medical University, Ministry of Healthcare of Russia, Radiologist of Radiology Department, Main Military Clinical Hospital named after academician N.N. Burdenko Russian Defense Ministry, Moscow
T. G. Morozova
Smolensk State Medical University;
Clinical Hospital No 1, Smolensk
Russian Federation
Russian Federation
Tat'jana G. Morozova – Doct. of Sci. (Med.), Head of Radiology Department of Smolensk State Medical University, Ministry of Healthcare of Russia, Radiologist of Radiology Department, Clinical Hospital No 1, Smolensk
References
1. Durleshter V.M., Gabriel' S.A., Korochanskaya N.V. et al. Managing liver cirrhosis: a multidisciplinary approach. Rossijskij zhurnal gastroenterologii, gepatologii, koloproktologii = Russian journal of gastroenterology, hepatology, coloproctology. 2020; 30 (4): 35–43. https://doi.org/10.22416/1382-4376-2020-30-4-35-43 (In Russian)
2. Moreno C., Mueller S., Szabo G. Non-invasive diagnosis and biomarkers in alcohol-related liver disease. J. Hepatology. 2019; 70 (2): 273–283. https://doi.org/10.1016/j.jhep.2018.11.025.
3. Simakina E.N., Morozova T.G. Improving the algorithm for the management of patients with viral hepatitis using contrast-free hepatic arterial spin labelling magnetic resonance perfusion. Vestnik rentgenologii i radiologii = Journal of radiology and nuclear medicine. 2021; 102 (5): 276–283. https://doi.org/10.20862/0042-4676-2021-102-5-276-283 (In Russian)
4. Pan X., Qian T., Fernandez-Seara M. et al. Quantification of liver perfusion using multidelay pseudocontinuous arterial spin labeling. JMRI. 2016; 43 (5): 1046–1054. https://doi.org/10.1002/jmri.25070
5. Taso M., Aramendía-Vidaurreta V., Englund E.K. Update on state-of-the-art for arterial spin labeling (ASL) human perfusion imaging outside of the brain. Magn. Reson. Med. 2023; 89: 1754–1776. https://doi.org/10.1002/mrm.29609
6. Mathew R.P., Venkatesh S.K. Imaging diffuse liver disease. Appl. Radiol. 2019; 48 (5): 13–20.
7. Li Y., Huang Y.S., Wang Z.Z., Yang Z.R., Sun F., Zhan S.Y. Systematic review with meta-analysis: The diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B. Aliment. Pharmacol. Ther. 2016; 43: 458–469. https://doi.org/10.1111/apt.13488
8. Zhang Y., Fowler K.J., Hamilton G. et al. Liver fat imaging. Clinical overview of ultrasound, CT, and MR imaging. Br. J. Radiol. 2018; 91 (1089): 20170959. https://doi.org/10.1259/bjr.20170959
9. Huber J., Günther M., Channaveerappa M., Hoinkiss, D.C. Towards free breathing 3D ASL imaging of the human liver using prospective motion correction. Magn. Reson. Med. 2022; 88 (2): 711–726. https://doi.org/10.1002/mrm.29234
10.
11.
Supplementary files
Review
For citations:
Telesh A.A., Morozova T.G. Liver non-contrast perfusion in diffuse liver diseases diagnostic algorithm: the new diagnostic criteria. Medical Visualization. 2024;28(3):136-145. (In Russ.) https://doi.org/10.24835/1607-0763-1419
Views:
295
Email this article 